COVIDNCT04377165
Innovative Tool to Limit Spread of COVID 19 in Residential Aged Care Facilities
A study testing Gamification and Newsfeed function in people with COVID and Influenza, run by The University of Queensland.
Trial summary
This project is a randomised trial in order to determine if "gamification" can result in behaviour change for healthcare workers in the residential aged care setting. The app is for Age Care and care workers at the front line who are working to protect those most vulnerable to COVID-19. Read more about this study
- Who is it for?
- Ages 18 to 90 yearsHealthy volunteers can take part
- Conditions the study is for
- COVID, Influenza, Gastroenteritis
- What is being tested?
- Gamification and Newsfeed function
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 34 participants
- Where
- No sites listed yet
- Study dates
- 6 May 2020to 26 Aug 2020
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 90 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Age Health Care Worker
Who cannot join
- -
About this study
Official title: Innovative Tool to Limit Spread of COVID 19 in Residential Aged Care
This project is a randomised trial in order to determine if "gamification" can result in behaviour change for healthcare workers in the residential aged care setting. The app is for Age Care and care workers at the front line who are working to protect those most vulnerable to COVID-19. There are 2 groups in this trial on group will receive current and accurate information from an app. The other group will receives the app with the addition of a gamification competent, this will include rewarding experiences for staff doing safety behaviours and wellbeing behaviours. The purpose of the gamification is to create a calming and reassuring experience that injects positivity and joy where possible during this stressful time.
Read the detailed description
The study design will be a multi- centre cluster randomised control trial, where Age Care facilities are randomised into two groups:
- Newsfeed- gets the app with newsfeed only
- Gamification group- gets the full gamified app, including the newsfeed Workers in our network of residential aged care facilities will be invited to participate in a study of communication of information regarding COVID-19 and how they will play a role in preventing its spread.
- Conditions
- COVID, Influenza, Gastroenteritis
- Being tested
- Gamification, Newsfeed function
- Keywords
- Infection Control
- Medical subject headings
- Influenza, Human, Gastroenteritis
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
GamificationBehavioural
This will provide the user with the newsfeed function and the addition of a gamification function
Newsfeed functionBehavioural
This will provide the user with reliable accurate information on the pandemic.
| Study group | Role | What they receive |
|---|---|---|
| Newsfeed | Active comparator | This will provide you with reliable accurate information on the pandemic. Receives: Behavioral: Newsfeed function |
| Gamification | Experimental | The gamification function will allow users to earn points for actions completed. The gamification function has links to resources for infection control, watching or completing tasks or playing games to earn points. Points can be viewed at a facility level, state level or national level. Receives: Behavioral: Gamification |
What is being measured
The primary outcome is the main question the study is designed to answer.
To compare the hours of sick leave used over the course of the 4-week period post randomisation for each group
Compare the number of sick leave prior to users utilising the app and at the end of the 4 weeks between the arms
Measured: 4 weeks
Secondary outcomes (10)
To compare handwashing behaviour
Compare the amount of soap/sanitiser used between the arms
Measured: 4 weeks
To compare self-testing rates
Compare the number of self tests between the two arms
Measured: 4 weeks
To compare the level of surface wipe down
Compare the amount of wipes/disinfectant used between the two arms
Measured: 4 weeks
To compare number of COVID-19 tests completed in Facilities
Compare the number of COVID-19 tests between the two arms
Measured: 4 weeks
To compare the number of COVID 19 infections in facilities
Compare the number of COVID-19 infections between the arms
Measured: 4 weeks
To compare the other types of outbreaks (Flu, gastroenteritis)
Compare the number of flu and gastroenteritis outbreaks between the arms
Measured: 4 weeks
To compare the awareness of COVID 19 training available to workers in the facilities
Compare the COVID 19 training between the two arms, this is via a self reported survey
Measured: 4 weeks
To compare the awareness of PPE training available to workers in the facilities
Compare the awareness of PPE training of the workers in the two arms, this is captured in self reported survey
Measured: 4 weeks
To compare the levels of PPE material used in
Compare the amount of PPE used between the arms
Measured: 4 weeks
To compare the wellbeing and self-efficacy of the two groups
Compare the wellbeing and self-efficacy between the two arms, this is captured in a self reported survey.
Measured: 4 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 May 2020
- Study start6 May 2020
- Primary completion26 Aug 2020
- Study completion26 Aug 2020
Why it stopped: Engagement issues, poor recruitment to study
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for COVIDStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Sequential
- Masking
- None (open label)
- Enrolment
- 34 participants (actual)
Sponsor and investigators
- Lead sponsor
- The University of Queensland
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- David L Paterson, PhD, Principal investigator, The University of Queensland
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04377165
- Sponsor's protocol ID
- Care Collective Study
- Status last verified
- Apr 2020
- First submitted
- 4 May 2020
- Last updated
- 9 Mar 2021
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 9 Mar 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Innovative Tool to Limit Spread of COVID 19 in Residential Aged Care
- ClinicalTrials.gov ID
- NCT04377165
- Acronym / sponsor ID
- Care Collective Study
- Conditions
- COVID, Influenza, Gastroenteritis
- Keywords
- Infection Control
- Study type
- Interventional
- Recruitment status
- TerminatedReason stopped: Engagement issues, poor recruitment to study
- Enrolment
- 34 participants (actual)
- Lead sponsor
- The University of QueenslandUniversity, hospital or other
- Study start
- 6 May 2020 (actual)
- Primary completion
- 26 Aug 2020 (actual)
- Study completion
- 26 Aug 2020 (actual)
- First posted
- 6 May 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This project is a randomised trial in order to determine if "gamification" can result in behaviour change for healthcare workers in the residential aged care setting. The app is for Age Care and care workers at the front line who are working to protect those most vulnerable to COVID-19. There are 2 groups in this trial on group will receive current and accurate information from an app. The other group will receives the app with the addition of a gamification competent, this will include rewarding experiences for staff doing safety behaviours and wellbeing behaviours. The purpose of the gamification is to create a calming and reassuring experience that injects positivity and joy where possible during this stressful time.
Detailed description
The study design will be a multi- centre cluster randomised control trial, where Age Care facilities are randomised into two groups:
- Newsfeed- gets the app with newsfeed only
- Gamification group- gets the full gamified app, including the newsfeed Workers in our network of residential aged care facilities will be invited to participate in a study of communication of information regarding COVID-19 and how they will play a role in preventing its spread.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Sequential
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Newsfeed | Active comparator | Behavioral: Newsfeed functionThis will provide you with reliable accurate information on the pandemic. |
| Gamification | Experimental | Behavioral: GamificationThe gamification function will allow users to earn points for actions completed. The gamification function has links to resources for infection control, watching or completing tasks or playing games to earn points. Points can be viewed at a facility level, state level or national level. |
Who may qualify
- Ages
- 18 to 90 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- Age Health Care Worker
Key exclusion criteria (1 listed)
- -
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| GamificationThis will provide the user with the newsfeed function and the addition of a gamification function | Behavioural | Gamification |
| Newsfeed functionThis will provide the user with reliable accurate information on the pandemic. | Behavioural | Newsfeed |
Primary outcome
To compare the hours of sick leave used over the course of the 4-week period post randomisation for each group
Time frame: 4 weeks
Compare the number of sick leave prior to users utilising the app and at the end of the 4 weeks between the arms
10 secondary outcomes
To compare handwashing behaviour
Time frame: 4 weeks
To compare self-testing rates
Time frame: 4 weeks
To compare the level of surface wipe down
Time frame: 4 weeks
To compare number of COVID-19 tests completed in Facilities
Time frame: 4 weeks
To compare the number of COVID 19 infections in facilities
Time frame: 4 weeks
To compare the other types of outbreaks (Flu, gastroenteritis)
Time frame: 4 weeks
To compare the awareness of COVID 19 training available to workers in the facilities
Time frame: 4 weeks
To compare the awareness of PPE training available to workers in the facilities
Time frame: 4 weeks
To compare the levels of PPE material used in
Time frame: 4 weeks
To compare the wellbeing and self-efficacy of the two groups
Time frame: 4 weeks
Results and safety
The study was stopped early (reason given: Engagement issues, poor recruitment to study). Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Mar 2021.
- Individual participant dataSharing planned: No
Related trials for COVID
Not yet recruitingPhase 1
Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post- Acute Sequelae of SARS-CoV-2 (PD1-PASC I)
Post-Acute COVID-19 Syndrome
Active, not recruitingPhase 1
A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults
COVID-19
Enrolling by invitation
Personalized Ventilator Settings for Patients on ECMO
Acute Respiratory Distress Syndrome (ARDS), Extracorporeal Membrane Oxygenation
Recruiting
Home-Based Exercise Tele-Rehabilitation After COVID-19
Post SARS-CoV2 (COVID-19)
Not yet recruitingPhase 1
A Safety, Reactogenicity and Immunogenicity Trial of RVX-sCPD9 Booster Intranasal COVID-19 Vaccine
COVID -19
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
David L Paterson, PhD principal investigator
The University of Queensland
Questions about this trial
What is this clinical trial studying?
A study testing Gamification and Newsfeed function in people with COVID and Influenza, run by The University of Queensland.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: stopped early, as of the sponsor's last update on 9 Mar 2021. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study was stopped early (reason given: Engagement issues, poor recruitment to study). Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
To compare the hours of sick leave used over the course of the 4-week period post randomisation for each group (time frame: 4 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Mar 2021.